5-93585063-G-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 1P and 5B. PP2BP6BS2
The NM_005654.6(NR2F1):c.40G>T(p.Asp14Tyr) variant causes a missense change. The variant allele was found at a frequency of 0.00000869 in 1,035,618 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.000048 ( 1 hom., cov: 30)
Exomes 𝑓: 0.0000022 ( 0 hom. )
Consequence
NR2F1
NM_005654.6 missense
NM_005654.6 missense
Scores
2
9
8
Clinical Significance
Conservation
PhyloP100: 3.81
Genes affected
NR2F1 (HGNC:7975): (nuclear receptor subfamily 2 group F member 1) The protein encoded by this gene is a nuclear hormone receptor and transcriptional regulator. The encoded protein acts as a homodimer and binds to 5'-AGGTCA-3' repeats. Defects in this gene are a cause of Bosch-Boonstra optic atrophy syndrome (BBOAS). [provided by RefSeq, Apr 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), NR2F1. . Gene score misZ: 4.1652 (greater than the threshold 3.09). Trascript score misZ: 4.6855 (greater than threshold 3.09). The gene has 51 curated pathogenic missense variants (we use a threshold of 10). The gene has 7 curated benign missense variants. GenCC has associacion of the gene with Bosch-Boonstra-Schaaf optic atrophy syndrome.
BP6
Variant 5-93585063-G-T is Benign according to our data. Variant chr5-93585063-G-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 709390.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=1, Likely_benign=1}.
BS2
High AC in GnomAd4 at 7 AD gene.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000479 AC: 7AN: 146252Hom.: 1 Cov.: 30
GnomAD3 genomes
AF:
AC:
7
AN:
146252
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00000225 AC: 2AN: 889366Hom.: 0 Cov.: 30 AF XY: 0.00000238 AC XY: 1AN XY: 420086
GnomAD4 exome
AF:
AC:
2
AN:
889366
Hom.:
Cov.:
30
AF XY:
AC XY:
1
AN XY:
420086
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000479 AC: 7AN: 146252Hom.: 1 Cov.: 30 AF XY: 0.0000562 AC XY: 4AN XY: 71144
GnomAD4 genome
AF:
AC:
7
AN:
146252
Hom.:
Cov.:
30
AF XY:
AC XY:
4
AN XY:
71144
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 05, 2024 | The c.40G>T (p.D14Y) alteration is located in exon 1 (coding exon 1) of the NR2F1 gene. This alteration results from a G to T substitution at nucleotide position 40, causing the aspartic acid (D) at amino acid position 14 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 15, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T;T;.;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
.;D;T;D
M_CAP
Pathogenic
D
MetaRNN
Uncertain
D;D;D;D
MetaSVM
Uncertain
D
MutationAssessor
Benign
N;N;.;.
PrimateAI
Pathogenic
D
PROVEAN
Benign
.;N;.;.
REVEL
Uncertain
Sift
Uncertain
.;D;.;.
Sift4G
Uncertain
.;D;.;D
Polyphen
P;P;.;.
Vest4
0.33, 0.34
MutPred
Gain of phosphorylation at D14 (P = 0.0046);Gain of phosphorylation at D14 (P = 0.0046);Gain of phosphorylation at D14 (P = 0.0046);Gain of phosphorylation at D14 (P = 0.0046);
MVP
0.77
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at